Skip to main content
Clinical Trials/NCT06894563
NCT06894563Not yet recruitingNot Applicable

On the Move: Center and Home-Based Exercise to Enhance Mobility in Diabetic Foot Ulcer Recovery

University of Maryland, Baltimore0 sites60 target enrollmentStarted: June 1, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
60
Primary Endpoint
6-minute walk distance

Study Overview

Brief Summary

Foot ulcers and amputations are a common and feared complication for people with diabetes. People with a diabetic foot ulcer have a higher risk of dying within five years than people with diabetes without an ulcer. At least one in four people with a new diabetic foot ulcer will die within five years, largely due to cardiovascular causes. The reasons for this increased mortality involve decreased mobility.

People with a recently healed diabetic foot ulcer are considered "in remission" as opposed to "cured" because the underlying medical problems (e.g., peripheral neuropathy, peripheral arterial disease) which led to their ulcer are still present. Once in remission, the current standard of care is to slowly increase ambulation with appropriate footwear so as not to promote ulcer recurrence. The problem is that people rarely return to the recommended level of mobility. The ability to safely maintain mobility with aging is critical, as immobility is the leading cause of nursing home admissions.

This is a clinical trial to test the feasibility and acceptability of an exercise regimen that transitions from in-person to home-based. The investigators will also assess if this exercise regimen can increase mobility and function without increasing diabetic foot ulcer recurrence by improving mobility, lower extremity strength, lower extremity tissue perfusion and glycemic control.

Detailed Description

Population: 60 Veterans with a healed foot ulcer in the last 3-15 months

Site: VA Maryland Health Care System (VAMHCS)

Study Duration: Approximately 3 years

Study Design: Randomized, outcome assessor blinded, clinical trial comparing a) a 12-week exercise regimen to b) standard of care

Objectives:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
50 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults >= 50 years
  • •Diagnosis of diabetes
  • •Plantar foot ulcer which healed within the last 3-15 months
  • •Two feet (can have healed minor amputations of fore and midfoot)
  • •Willing to wear appropriately fitted footwear for exercise regimen
  • •Ambulatory without walker
  • •Willing to enroll in the PODIMETRICS SmartMat program
  • •Able to give written informed consent

Exclusion Criteria

  • •Unable to perform the exercise interventions (e.g. due to hearing or visual impairment)
  • •Anticipated foot surgery in the next 4 months
  • •Participating in another exercise program
  • •Severe peripheral arterial disease (Fontaine stage 3 rest pain or 4 ischemic ulcers/gangrene)
  • •Current plantar foot ulcer
  • •Any other criteria which, in the investigator's opinion, would compromise the ability of a subject to participate safely

Arms & Interventions

12-week exercise regimen

Experimental

Consistent with current physical activity recommendations for older adults, participants randomized in this arm will be prescribed 5 days/week of exercise, with seated cycling exercise performed on 3 days a week and strength/balance exercise performed 2 days a week.

Intervention: 12-week exercise regimen (Behavioral)

12-week standard of care

Placebo Comparator

Participants in this group will be provided with guidance on the current standard of care. This includes guidance that these patients should slowly increase ambulation with appropriately fitted footwear.

Intervention: 12-week standard of care (Behavioral)

Outcomes

Primary Outcomes

6-minute walk distance

Time Frame: 12 weeks

Using standard procedures participants will be asked to walk as far as possible in 6 minutes along a 100-foot course. Primary clinical outcome is total distance covered.

Secondary Outcomes

  • Perfusion(12 weeks)
  • Glycemic Control(12 weeks)
  • Acceptability and Feasibility(12 weeks)
  • Adherence to the exercise regimen(12 weeks)
  • SmartMat metrics(12 weeks)
  • Community Mobility(12 weeks)
  • Mobility Function(12 weeks)
  • Physical Activity(12 weeks)
  • Muscular strength(12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials